Grifols SA ADR (NASDAQ: GRFS) kicked off on Tuesday, down -2.64% from the previous trading day, before settling in for the closing price of $7.19. Over the past 52 weeks, GRFS has traded in a range of $5.30-$12.15.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 6.28%. While this was happening, its average annual earnings per share was recorded 112.20%. With a float of $256.76 million, this company’s outstanding shares have now reached $256.91 million.
The extent of productivity of a business whose workforce counts for 23744 workers is very important to gauge.
Grifols SA ADR (GRFS) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – General Industry. The insider ownership of Grifols SA ADR is 0.06%, while institutional ownership is 53.68%.
Grifols SA ADR (GRFS) Latest Financial update
In the latest quarterly report, which was put into the public domain on 3/31/2024, the organization reported 0.15 earnings per share (EPS), lower than consensus estimate (set at 0.18) by -0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.24 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 112.20% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 66.10% during the next five years compared to -37.97% drop over the previous five years of trading.
Grifols SA ADR (NASDAQ: GRFS) Trading Performance Indicators
Take a look at Grifols SA ADR’s (GRFS) current performance indicators. Last quarter, stock had a quick ratio of 1.29. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.25.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.25 and is forecasted to reach 1.11 in one year’s time.
Technical Analysis of Grifols SA ADR (GRFS)
The latest stats from [Grifols SA ADR, GRFS] show that its last 5-days average volume of 1.09 million was inferior to 2.28 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 52.47%. Additionally, its Average True Range was 0.24.
During the past 100 days, Grifols SA ADR’s (GRFS) raw stochastic average was set at 41.77%, which indicates a significant increase from 30.14% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 28.00% in the past 14 days, which was lower than the 73.01% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.99, while its 200-day Moving Average is $8.16. Now, the first resistance to watch is $7.07. This is followed by the second major resistance level at $7.13. The third major resistance level sits at $7.19. If the price goes on to break the first support level at $6.95, it is likely to go to the next support level at $6.89. The third support level lies at $6.83 if the price breaches the second support level.
Grifols SA ADR (NASDAQ: GRFS) Key Stats
The company with the Market Capitalisation of 1.80 billion has total of 687,560K Shares Outstanding. Its annual sales at the moment are 7,135 M in contrast with the sum of 64,200 K annual income. Company’s last quarter sales were recorded 2,025 M and last quarter income was 58,780 K.
